Inflammatory Mediators in Diabetic Macular Edema: A Prospective, Controlled Study.

Area of Science:

• Ophthalmology
• Endocrinology
• Immunology

Background:

• Diabetic macular edema (DME) is a leading cause of vision loss in diabetic patients.
• Inflammatory cytokines play a crucial role in the development and progression of DME.
• Previous studies on cytokine associations with DME have been limited by small sample sizes and study design.

Purpose of the Study:

• To rigorously analyze the association between 24 inflammatory cytokines and DME in a prospective cohort.
• To investigate the role of specific cytokines in different stages of diabetic retinopathy severity.
• To identify potential biomarkers for DME.

Main Methods:

• Prospective trial involving 164 adult type II diabetic patients (328 eyes).
• Collected data included ETDRS visual acuity, fundus photography, and OCT.
• Measured aqueous humor cytokine levels using a multiplex assay and defined DME based on OCT criteria.

Main Results:

• Elevated levels of Interleukin-8 (IL-8), FLT-3 ligand (FLT-3L), Fibroblast Growth Factor 2 (FGF-2), Interleukin-6 (IL-6), and Interleukin-10 (IL-10) were significantly associated with DME.
• Odds ratios indicated a positive association for IL-8 (2.73), FLT-3L (2.27), FGF-2 (1.74), IL-6 (2.93), and IL-10 (2.79) in eyes with DME.
• Median levels of IL-6 and IL-8 were higher in eyes with DME compared to those without.

Conclusions:

• IL-8, FLT-3L, FGF-2, IL-6, and IL-10 are significantly elevated in eyes affected by DME.
• These cytokines represent potential therapeutic targets for managing DME.
• The findings provide a stronger basis for understanding DME pathophysiology through cytokine analysis.